Company's Second Major Acquisition Will Extend Orphan and Rare Disease Research Base and Growth Opportunities ROCKVILLE, Md., May 12, 2021 /PRNewswire/ Emmes, a global, full-service
/PRNewswire/ Emmes (the "Company"), a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and.
Rhonda Henry has joined Emmes’ BioPharma Group (Rockville, Md.) as president.
The Wilmington native has 30 years of clinical research experience, most recently as vice president of patient solutions at PPD.
In 2020, she was named to the PharmaVOICE 100 list of most inspiring people working in the life-sciences industry.
Before joining PPD, she spent eight years at New Hanover Regional Medical Center, starting as a phlebotomist and completing her tenure there as a nurse in medical/surgical and neurology areas.
According to Henry, “Two of the things that attracted me to Emmes were its excellent reputation and its 40-plus years in clinical research. The opportunity to work with Christine again, along with the conversations I had with members of Emmes’ leadership team, had a big impact on my decision.